Navigation Links
LBA and Hybrid LCMS Quantitation of Biotherapeutics and Biomarkers, Upcoming Webinar Hosted by Xtalks
Date:6/23/2020

The field of quantitation of large molecules or proteins has been around for a long time. Typically, ligand binding assays (LBA) have dominated this area. However, the use of mass spectrometry in this field has gained a lot of momentum in the last several years.

This now necessitates the question “How do you choose which approach to use (LBA or MS)?” In many cases, either technology can answer the question, but there are definitely times when one technology has advantages over the other. There are several questions which might lead to specific direction, such as “what type of reagents are available?” or “do you need to differentiate a small amino acid change?”

This webinar will give an overview of each approach and discuss the types of questions that will help guide one to choose the correct technology. For the LBA, we will discuss the different types of ligand binding assays, answers to common questions that can lead to performing LBA vs. hybrid LCMS and some advantages of LBA over LCMS methodologies.

For Hybrid LCMS, we will discuss and highlight various approaches for using immunoaffinity LCMS or hybrid LCMS, from enrichment at the protein level to enrichment at the peptide level, using either bead-based or column-based enrichment strategies.

The presenters will also give examples and case studies of where each technology was applied successfully and where they had to pivot to an alternate technology.

Join Franklin Spriggs, MS Director, Biopharmaceutical LBA Services, KCAS Bioanalytical and Biomarker Services and Dawn Dufield, PhD, Director, Biopharmaceutical LC-MS/MS Services, KCAS Bioanalytical and Biomarker Services in a live webinar on Friday, July 10, 2020 at 12pm EDT (5pm BST/UK).

For more information or to register for this event, visit LBA and Hybrid LCMS Quantitation of Biotherapeutics and Biomarkers.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Read the full story at https://www.prweb.com/releases/lba_and_hybrid_lcms_quantitation_of_biotherapeutics_and_biomarkers_upcoming_webinar_hosted_by_xtalks/prweb17205839.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Boekel Scientific rapidFISH Hybridization Oven Used to Study the Effects of Humidity on a DNA Labeling System
2. Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020
3. How are hybridized species affecting wildlife?
4. Statistical model predicts performance of hybrid rice
5. LSTM Researchers demonstrate adaptive potential of hybridization in mosquito species
6. Study finds climate change accelerates hybridization between native, invasive trout
7. Hybrid technology could make Star Trek-style tricorder a reality
8. Hybrid vehicles more fuel efficient in India, China than in US
9. Solar-induced hybrid fuel cell produces electricity directly from biomass
10. Study discovers natural hybridization produced dolphin species
11. Researchers engineer a hybrid 5 times more effective in delivering genetic material into cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
(Date:8/21/2020)... ... 2020 , ... The 19th Annual Bio-IT World Conference ... informatics and IT leaders goes VIRTUAL and announces its updated event features and ... takes the leadership role of keeping our life science community connected by bringing ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in ... into license agreements with Housey Pharma’s HMI subsidiary to gain access to its ... annual Research and Development spending in excess of US $10 billion. , Scientists ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech ... Regulatory Solutions, in a one hour live webinar on Thursday, August 13, ... China for drugs and medical devices. Specifically, for medical devices, the NMPA has departments ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, ... of laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and ...
(Date:7/7/2020)... ... 2020 , ... Bio-IT World has announced the winners of ... University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were ... outstanding examples of how technology innovations and strategic initiatives can be powerful forces ...
(Date:6/28/2020)... ... June 25, 2020 , ... With ... a vaccine or drug treatment. In an effort to better understand the cellular ... the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 approved ...
Breaking Biology Technology: